Relationship between matrix metalloproteinase expression and tumor angiogenesis in human breast carcinoma

Oncology Reports

Volumn 5, Issue 3, 1998, Pages 673-677

  Kurizaki, Takashi ^a   Toi, Masakazu ^a   Tominaga, Takeshi ^a  

^a TOKYO METROPOLITAN KOMAGOME HOSPITAL   (Japan)

Author keywords

Angiogenesis; Breast neoplasm; Matrix metalloproteinase

Indexed keywords

GELATIN; GELATINASE A; GELATINASE B; MATRIX METALLOPROTEINASE; THYMIDINE PHOSPHORYLASE; VASCULOTROPIN;

ARTICLE; BREAST CARCINOMA; CANCER INVASION; CONTROLLED STUDY; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; PROTEIN EXPRESSION; TUMOR VASCULARIZATION; VASCULAR ENDOTHELIUM;

EID: 0031981094     PISSN: 1021335X     EISSN: None     Source Type: Journal    
DOI: 10.3892/or.5.3.673     Document Type: Article

References (30)

1. Folkman J: Angiogenesis in cancer, vascular, rheumatoid and other disease. Nat Med 1: 27-31, 1995.
2. O'Reilly MS, Holmgren L, Chen C and Folkman J: Angiostatin induces and sustains dormancy of human primary tumors in mice. Nat Med 2: 689-692, 1996.
3. Plate KH, Breier G and Risau W: Molecular mechanisms of developmental and tumor angiogenesis. Brain Pathol 4: 207-218, 1994.
4. Sava G, Capozzi I, Bergamo A, Gagliardi R, Cocchietto M, Masiero L, et al: Down-regulation of tumour gelatinase/ inhibitor balance and preservation of tumour endothelium by an anti-metastatic ruthenium complex. Int J Cancer 68: 60-66, 1996.
5. Johnson MD, Kim HC, Chesler L, Tsao-Wu G, Bouck N and Polverini PJ: Inhibition of angiogenesis by tissue inhibitor of metalloproteinase. J Cell Phys 160: 194-202, 1994.
6. Stetler-Stevenson WG, Liotta LA and Brown PD: Role of type-IV collagenases in human breast cancer. In: Genes, Oncogenes and Hormones: Advanced Cellular and Molecular Biology of Breast Cancer. Dickson RB and Lippman ME (eds.) Kluwer Academic Publishers, Boston, pp21-41, 1991.
7. Declerck YA, Perez N, Shimada H, Bonne TC, Langley KE and Taylor SM: Inhibition of invasion and metastasis in cells transfected with an inhibitor of metalloproteinases. Cancer Res 52: 701-708, 1992.
8. Toi M, Taniguchi T, Yamamoto Y, Kurizaki T, Suzuki H and Tminaga T: Clinical significance of the determination of angiogenic factors. Eur J Cancer 32A: 2513-2519, 1996.
9. Toi M, Hoshina S, Takayanagi T and Tominaga T: Association of vascular endothelial growth factor expression with tumor angiogenesis and with early relapse in primary breast cancer. Jpn J Cancer Res 85: 1045-1049, 1994.
10. Ferrara N: Vascular endothelial growth factor. Eur J Cancer 32A: 2413-2422, 1996.
11. Takahashi Y, Kitadai Y, Bucana CD, Cleary KR and Ellis LM: Expression of vascular endothelial growth factor and its receptor, KDR, correlates with vascularity, metastasis and proliferation of human colon cancer. Cancer Res 55: 3964-3968, 1995.
12. Gasparim G, Toi M, Gion M, Verderio P, Dittadi R, Hanatani M, Matsubara I, Vinante O, Bonoldi E, Boracchi P, Gatti C, Suzuki H and Tominaga T: Prognostic significance of vascular endothelial growth factor protein in node-negative breast carcinoma. J Natl Cancer Inst 89: 139-147, 1997.
13. Toi M, Hoshina S, Taniguchi T, Yamamoto Y, Ishitsuka H and Tominaga T: Expression of platelet-derived endothelial cell growth factor/thymidine phosphorylase in human breast cancer. Int J Cancer 64: 79-82, 1995.
14. Takebayashi Y, Akiyama S, Akiba S, Yamada K, Miyadera K, Sumizawa T, Yamada Y, Murata F and Aikou T: Clinicopathological and prognostic significance of an angiogenic factor, thymidone phosphorylase, in human colorectal carcinoma. J Natl Cancer Inst 88: 1110-1117, 1996.
15. Gasparini G and Harris AL: Clinical importance of the determination of tumor angiogenesis in breast carcinoma: Much more than a new prognostic tool. J Clin Oncol 13: 765-782, 1995.
16. Greene J, Wang M, Liu YE, Raymond LA, Rosen C and Shi YE: Molecular cloning and chracterization of human tissue inhibitor of metalloproteinase 4. J Biol Chem 271: 30375-30380, 1996.
17. Tryggvarson K, Hoyhtya M and Pyke C: Type IV collagenases in invasive tumors. Breast Cancer Res Treat 24: 209-218, 1993.
18. Apte S, Olsen BR and Murphy G: The gene structure of tissue inhibitor of metalloproteinases (TIMP)-3 and its inhibitory activities define the distinct TIMP gene family. J Biol Chem 270: 14313-14318, 1995.
19. Davies B, Miles DW, Happerfield LC, Naylor MS, Bobrow LG, Rubens RD, et al: Activity of type IV collagenases in benign and malignant breast disease. Br J Cancer 67: 1126-1131, 1993.
20. Iwata H, Kobayashi S, Iwase H, Masaoka A, Fujimoto N and Okada Y: Production of matrix metalloproteinases and tissue inhibitors of metalloproteinases in human breast carcinomas. Jpn J Cancer Res 87, 602-611, 1996.
21. Clavel C, Polette M, Doco M, Binninger I and Birembaut P: Immunolocalization of matrix metallo-proteinases and their tissue inhibitor in human mammary pathology. Bull Cancer 79: 261-270, 1992.
22. Polette M, Clavel C, Cockett M, de Bentzmann SG, Murphy G and Birembaut P: Detection and localization of mRNAs encoding matrix metalloproteinases and their tissue inhibitor in human breast pathology. Invasion Metastasis 13: 31-37, 1993.
23. Johnatty R, Taub D, Reeder S, Turcovski-Corrales SM, Cottam DW, Stephenson TJ and Rees RC: Cytokine and chemokine regulation of pro MMP-9 and TIMP-1 production by human peripheral blood lymphocytes. J Immunol 158: 2327-2333, 1997.
24. Eda H, Fujimoto K, Watanabe S, et al: Cytokines induce thymidine phosphorylase expression in tumor cells and make them more susceptible to 5′-deoxy-5-fluorouridine. Cancer Chem Pharm 32: 333-338, 1993.
25. Toi M, Inada K, Hoshina S, Suzuki H, Kondo S and Tominaga T: Vascular endothelial growth factor and platelet-derived endothelial cell growth factor are frequently co-expressed in highly vascularized human breast cancer. Clin Cancer Res 1: 961-964, 1995.
26. Griffiths L, Dachs GU, Bicknell R, Harris AL and Stratford IJ: The influence of oxygen tension and pH on the expression of platelet-derived endothelial cell growth factor/thymidine phosphorylase in human breast tumor growth in vitro and in vivo. Cancer Res 57: 570-572, 1997.
27. Puente XS, Pendas AM, Llano E, Velasco G and Lopez-Otin C: Molecular cloning of a novel membrane-type matrix metalloproteinase from a human breast carcinoma. Cancer Res 56: 944-949, 1996.
28. Ueno H, Nakamura H, Inoue M, Imai K, Noguchi M, Sato H, Seiki M and Okada Y: Expression of tissue localization of membrane types 1, 2 and 3 matrix metalloproteinases in human invasive breast carcinoma. Cancer Res 57: 2055-2060, 1997.
29. Leek RD, Lewis CE, Whitehouse R, Greenall M, Clarke J and Harris AL: Association of macrophage infiltration with angiogenesis and prognosis in invasive breast carcinoma. Cancer Res 56: 4625-4629, 1996.
30. Brown PD: Matrix metalloproteinase inhibitors. Angiogenesis 1: 142-154, 1997.